Gail Maderis is the founder of Antiva Biosciences. Antiva Biosciences has raised $100M in total funding. Latest round: Series E.
Gail Maderis is the former President and CEO of Antiva Biosciences, a biopharmaceutical company focused on developing topical therapeutics for HPV-related pre-cancerous lesions. She led the company through several funding rounds, including a $31 million Series D and a $53 million Series E.
Full founder directory · Investor directory · Company funding database · Fundraising library